SPPG issued correspondence on Monday 22 May 2023 providing an update in relation to the provision of PPE to community pharmacies.
SUMMARY
Contractors will note:
Prior to the pandemic, Community Pharmacies were responsible for sourcing (and paying for) their own PPE.
However during the COVID-19 pandemic, the Department of Health provided PPE free of charge to the Community Pharmacy network since March 2020.
Updated IPC guidance recently issued by PHA recommends a return to the application of standard and transmission-based precautions when dealing with respiratory illnesses.
The recommendation for universal masking in all health and social care settings including care homes has been removed.
Almost 11,000 individuals have received their COVID-19 spring booster vaccine from community pharmacists across NI since the beginning of the spring campaign.
This includes over 8,000 care home residents from 334 (74%) homes.
Care Home Residents:
There is now one full week left to complete care home resident vaccinations.
The operational target for completing care home resident vaccinations (including those missed in original clinics) is next Wednesday 31 May 2023.
There are now five weeks left of the 2023 COVID-19 spring booster programme, which runs until 30 June 2023.
Until this date community pharmacists should continue to plan and operate clinics for all eligible individuals, for primary and booster vaccinations.
Community pharmacies who have signed a contract to provide the CPVS spring booster will be displayed on the NI direct map advertising the service.
Where eligible individuals contact pharmacy seeking vaccination, arrangements should be made for this to take place.
Movianto records indicate a number of pharmacies have not yet ordered vaccine.
Please ensure you have adequate vaccine stock available to accommodate vaccine requests from eligible individuals.
Community pharmacy spring 2023 vaccine product
The COVID-19 adult vaccine PGD is used by trusts, community pharmacists and general practice and therefore lists both the Pfizer and Sanofi spring vaccines currently used throughout NI.
However, Comirnaty Original/Omicron BA.4-5 is the only vaccine which was deployed for use by community pharmacists delivering the CPVS for all eligible individuals 18 years +.
ACTION
Contractors providing the CPVS are asked to:
Review CPVS Update 6, and the previous updates (1-5 linked above) if not already reviewed.
Take note of the deadline for completion of the vaccination of care home residents by 31 May 2023 and ensure the necessary plans are in place.
Take note of the completion date for the Spring Booster programme by 30 June 2023.
Ensure pharmacies have adequate stocks of the Comirnaty Original/Omicron BA.4-5 vaccine.
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor
SPPG issued correspondence on Monday 22 May 2023 advising those pharmacies who participate in the Community Pharmacy Living Well Service, that access to the campaign surveys has now been reinstated.
SUMMARY
Contractors will note:
Living Well surveys had been on hold but are now reinstated and are available here.
Previous survey weblinks (survey monkey) can no longer be used.
Community pharmacies will receive the usual correspondence to notify of the survey launches prior to a campaign finishing.
Access to this survey will be emailed to pharmacies week commencing 5th June 2023.
General requirements:
When completing evaluation surveys please ensure you use the correct contractor number.
It is vital that all pharmacies contracted to provide “Living Well” submit their evaluation survey after each campaign as it allows SPPG to collate data to demonstrate the value and impact of the service to other sectors, and supports future commissioning and service development.
Failure to submit evaluation data may result in full or partial recovery of a community pharmacy’s Living Well funding.
ACTION
Contractors participating in the Living Well service should:
Note the details in the correspondence and share with any relevant members of the pharmacy team.
Contractors should contact CPNI offices should they have any queries or should their staff experience any difficulties in accessing or completing the surveys.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
PRELIMINARY NOTICE is hereby given that the Third Annual General Meeting of the Members of the Company will be held at 4.00pm on Thursday 8th June 2023, immediately after the June 2023 CPNI Board meeting, for the purpose of considering the following business:
1. Notice of meeting.
2. Apologies for absence.
3. Minutes of CPNI AGM held on 23rd June 2022.
4. Chairman’s Report.
5. Report on the Summary Income Statement and Balance Sheet for the year ended 31 October 2021.
6. Appointment of Auditors.
7. Appointment of Solicitors.
8. Closing remarks by the Chairman.
AGM papers will be sent out by post w/c 29th May 2023.
Any member wishing to submit a Notice of Motion should complete the Notice of Motion pro-forma HERE and ensure it is returned to CPNI offices no later than Friday 26th May 2023.
Members are asked to confirm their attendance, or otherwise, to info@communitypharmacyni.co.uk on or before Wednesday 24th May 2023 for the purposes of finalising the venue for the AGM.
By order of the Board
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
The Department of Health NI has issued correspondence on 22 May 2023 (dated 19 May 2023) in respect of Utrogestan 100mg capsules.
DETAILS
SSPs made under the Human Medicines Regulations 2012 are an additional tool to manage and mitigate medicines shortages.
SSPs enable community pharmacists to supply specified medicines in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber – saving time for patients, pharmacists and prescribers.
DHNI has advised that SSP056 enables community pharmacists across the UK to supply patients with no more than two months’ worth of supply of Utrogestan® 100mg capsules, where the total quantity specified on the prescription exceeds two months’ worth of supply. The protocol allows for a reduced quantity of Utrogestan® 100mg capsules to be supplied to help manage the ongoing supply disruption affecting this product.
Pharmacists should refer to the latest versions of SSPs which are available on the Business Services Organisation dedicated page on its website here.
ACTION
Contractors are asked to:
Note that SSP056 relating to Utrogestan 100mg capsules has been issued;
Review the DHNI letter dated 19 May 2023 and ensure that dispensary teams are aware of it; and
Note the details contained within this letter relating to the decision pathways for SSPs; notification of GPs; the need for patient/carer agreement, and action to take when this is not given; professional judgement; and actions regarding unclear quantities.
Contractors should contact their local SPPG office in the first instance should further information be required. CPNI colleagues are also available for assistance.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
Contractors are encouraged to select candidates to fill the 4 spaces on the Board of the Pharmacy Forum of Northern Ireland in the elections which close tomorrow at 12 noon, Tuesday 23rd May 2023.
Further details of the candidates and how to vote are contained below.
PHARMACY FORUM NIBOARD ELECTIONS 2023
Voting in the Pharmacy Forum NI 2023 Board Elections closes at noon tomorrow.
Seven candidates are standing, and there are four spaces to be filled.
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.